EUVIMEDEUVIMED entdecken
Crossref

Familial Hypercholesterolemia Screening: From Pediatric Detection to Life-long Management

Tomoko Inoue, Hayato Tada, Tetsuo Minamino

Journal of Atherosclerosis and Thrombosis · 2026

DOI: 10.5551/jat.rv22063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2026. Verfasst von Tomoko Inoue und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia (FH) is a common autosomal dominant disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels from birth and an increased lifetime risk of atherosclerotic cardiovascular disease (ASCVD). Early identification and treatment are therefore essential to reduce cumulative LDL-C exposure. Several approaches to FH screening have been proposed, including cascade, reverse cascade, opportunistic, selective, and universal screening, each with distinct advantages, limitations, and implementation requirements. In particular, pediatric screening provides an opportunity for early diagnosis and treatment while also facilitating the identification of affected family members. Screening programs have been implemented differently across countries and regions according to healthcare systems and existing screening infrastructure, with regional universal screening programs also emerging in Japan.However, the value of FH screening extends beyond case detection. Individuals identified through screening should be linked to a definitive diagnosis, risk assessment, treatment, family-based management, and life-long follow-up. This review summarizes current FH screening strategies and their international implementation, with particular emphasis on pediatric detection, and discusses subsequent clinical management and future approaches to sustainable life-long care. Integrating effective screening with coordinated healthcare delivery systems is essential to translate early detection into long-term ASCVD prevention.

Schlagwörter

Stichwörter der Autor:innen

Familial HypercholesterolemiaLife-long managementPediatricScreening

Autor:innen und Institutionen

  • Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University.
  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University.

Zitieren

APA

Inoue, T., Tada, H., & Minamino, T. (2026). Familial Hypercholesterolemia Screening: From Pediatric Detection to Life-long Management. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv22063

Vancouver

Inoue T, Tada H, Minamino T. Familial Hypercholesterolemia Screening: From Pediatric Detection to Life-long Management. Journal of Atherosclerosis and Thrombosis. 2026. doi:10.5551/jat.rv22063

BibTeX
@article{Inoue2026,
  author = {Inoue, Tomoko and Tada, Hayato and Minamino, Tetsuo},
  title = {Familial Hypercholesterolemia Screening: From Pediatric Detection to Life-long Management},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  doi = {10.5551/jat.rv22063}
}
Kostenlos starten →